3-51985845-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_000666.3(ACY1):c.265-7C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000257 in 1,612,310 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000666.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACY1 | NM_000666.3 | c.265-7C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000636358.2 | NP_000657.1 | |||
ABHD14A-ACY1 | NM_001316331.2 | c.535-7C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001303260.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACY1 | ENST00000636358.2 | c.265-7C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000666.3 | ENSP00000490149 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000334 AC: 83AN: 248566Hom.: 1 AF XY: 0.000498 AC XY: 67AN XY: 134464
GnomAD4 exome AF: 0.000264 AC: 386AN: 1460008Hom.: 1 Cov.: 32 AF XY: 0.000340 AC XY: 247AN XY: 726198
GnomAD4 genome AF: 0.000190 AC: 29AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74470
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | - - |
ABHD14A-ACY1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 06, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at